Ilia I. Ouspenski

Array ( [id] => 6977420 [patent_doc_number] => 20050287136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Human monoclonal antibodies to CTLA-4' [patent_app_type] => utility [patent_app_number] => 11/128900 [patent_app_country] => US [patent_app_date] => 2005-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 32223 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20050287136.pdf [firstpage_image] =>[orig_patent_app_number] => 11128900 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4445355 [patent_doc_number] => 07863418 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-04 [patent_title] => 'T-cell membrane protein (TIRC7) and peptides derived therefrom' [patent_app_type] => utility [patent_app_number] => 11/126866 [patent_app_country] => US [patent_app_date] => 2005-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 19260 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/863/07863418.pdf [firstpage_image] =>[orig_patent_app_number] => 11126866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7168376 [patent_doc_number] => 20050202013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Novel Th2-specific molecules and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/120777 [patent_app_country] => US [patent_app_date] => 2005-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 33312 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20050202013.pdf [firstpage_image] =>[orig_patent_app_number] => 11120777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 211659 [patent_doc_number] => 07622565 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-24 [patent_title] => 'Nucleic acids encoding B7-H4, a T cell immunoregulatory molecule' [patent_app_type] => utility [patent_app_number] => 11/120927 [patent_app_country] => US [patent_app_date] => 2005-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 19 [patent_no_of_words] => 14957 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/622/07622565.pdf [firstpage_image] =>[orig_patent_app_number] => 11120927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8543613 [patent_doc_number] => 08318905 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-27 [patent_title] => 'Antibodies for depletion of ICOS-positive cells in vivo' [patent_app_type] => utility [patent_app_number] => 11/578215 [patent_app_country] => US [patent_app_date] => 2005-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12358 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11578215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7135945 [patent_doc_number] => 20050180966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Method for treating autoimmune diseases' [patent_app_type] => utility [patent_app_number] => 11/098947 [patent_app_country] => US [patent_app_date] => 2005-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4954 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20050180966.pdf [firstpage_image] =>[orig_patent_app_number] => 11098947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6925396 [patent_doc_number] => 20050238651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Treatment of inflammatory bowel disease' [patent_app_type] => utility [patent_app_number] => 11/095946 [patent_app_country] => US [patent_app_date] => 2005-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 15317 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20050238651.pdf [firstpage_image] =>[orig_patent_app_number] => 11095946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 588781 [patent_doc_number] => 07435596 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-14 [patent_title] => 'Modified cell line and method for expansion of NK cell' [patent_app_type] => utility [patent_app_number] => 11/074525 [patent_app_country] => US [patent_app_date] => 2005-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8635 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/435/07435596.pdf [firstpage_image] =>[orig_patent_app_number] => 11074525 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4970744 [patent_doc_number] => 20070110746 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-17 [patent_title] => 'Pharmaceutical composition for treatment of immunological disorders' [patent_app_type] => utility [patent_app_number] => 10/539946 [patent_app_country] => US [patent_app_date] => 2005-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 13647 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20070110746.pdf [firstpage_image] =>[orig_patent_app_number] => 10539946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6977436 [patent_doc_number] => 20050287152 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Compositions and methods to modulate an immune response to an immunogenic therapeutic agent' [patent_app_type] => utility [patent_app_number] => 11/057923 [patent_app_country] => US [patent_app_date] => 2005-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9522 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20050287152.pdf [firstpage_image] =>[orig_patent_app_number] => 11057923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1076700 [patent_doc_number] => 07615211 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-10 [patent_title] => 'CD70 inhibition for the treatment and prevention of inflammatory bowel disease' [patent_app_type] => utility [patent_app_number] => 11/053285 [patent_app_country] => US [patent_app_date] => 2005-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 19 [patent_no_of_words] => 9336 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/615/07615211.pdf [firstpage_image] =>[orig_patent_app_number] => 11053285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7004557 [patent_doc_number] => 20050169870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Methods of modulating CD200' [patent_app_type] => utility [patent_app_number] => 11/047456 [patent_app_country] => US [patent_app_date] => 2005-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14627 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20050169870.pdf [firstpage_image] =>[orig_patent_app_number] => 11047456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7168272 [patent_doc_number] => 20050201994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Human CTLA-4 antibodies and their uses' [patent_app_type] => utility [patent_app_number] => 11/040846 [patent_app_country] => US [patent_app_date] => 2005-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 38655 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20050201994.pdf [firstpage_image] =>[orig_patent_app_number] => 11040846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4585001 [patent_doc_number] => 07851598 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-14 [patent_title] => 'Receptor modulators' [patent_app_type] => utility [patent_app_number] => 10/585491 [patent_app_country] => US [patent_app_date] => 2005-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 2 [patent_no_of_words] => 81226 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 163 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/851/07851598.pdf [firstpage_image] =>[orig_patent_app_number] => 10585491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5590458 [patent_doc_number] => 20060039909 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Human CD28 specific monoclonal antibodies for antigen-non-specific activation of T-lymphocytes' [patent_app_type] => utility [patent_app_number] => 11/019530 [patent_app_country] => US [patent_app_date] => 2004-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 5070 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20060039909.pdf [firstpage_image] =>[orig_patent_app_number] => 11019530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4964827 [patent_doc_number] => 20080107647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'Methods and Compositions Relating to Ccr5 Antagonist, Inf-Y and Il-13 Induced Inflammation' [patent_app_type] => utility [patent_app_number] => 10/582610 [patent_app_country] => US [patent_app_date] => 2004-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 20660 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20080107647.pdf [firstpage_image] =>[orig_patent_app_number] => 10582610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 813848 [patent_doc_number] => 07414122 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-19 [patent_title] => 'Nucleic acids encoding B7-Like molecules and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/998526 [patent_app_country] => US [patent_app_date] => 2004-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 36207 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/414/07414122.pdf [firstpage_image] =>[orig_patent_app_number] => 10998526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7182677 [patent_doc_number] => 20050191276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'Treatment of inflammatory bowel disease through induction of indoleamine 2.3-dioxygenase' [patent_app_type] => utility [patent_app_number] => 10/997147 [patent_app_country] => US [patent_app_date] => 2004-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8370 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20050191276.pdf [firstpage_image] =>[orig_patent_app_number] => 10997147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 415383 [patent_doc_number] => 07279567 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-09 [patent_title] => 'Polynucleotides-encoding B7-related polypeptide, BSL2-L165-35B' [patent_app_type] => utility [patent_app_number] => 10/994824 [patent_app_country] => US [patent_app_date] => 2004-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 46 [patent_no_of_words] => 43597 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/279/07279567.pdf [firstpage_image] =>[orig_patent_app_number] => 10994824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5887508 [patent_doc_number] => 20060275254 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Pharmaceutical composition comprising an immunoglobulin fc region as a carrier' [patent_app_type] => utility [patent_app_number] => 10/535231 [patent_app_country] => US [patent_app_date] => 2004-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 18233 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20060275254.pdf [firstpage_image] =>[orig_patent_app_number] => 10535231 [rel_patent_id] =>[rel_patent_doc_number] =>)